Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The MIC B12 injection combines specific nutrients which work together to support metabolic function
Philadelphia: Lippincott, Williams & Wilkins
Any perceived weight loss benefits likely stem from correcting an underlying deficiency that was causing fatigue, rather than from any inherent fat-burning mechanism
This proactive approach strengthens your bodys natural defenses, offsets the effects of modern-day stress, and promotes long-term vitality
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
US$ 24.87
US$ 25.36
US$ 28.54
